3696.HK+36.46%16.7%
ARQT+76.43%16.7%
HALO+34.13%16.7%
OBIO+59.85%16.7%
VCEL+24.99%16.7%
WVE-30.64%16.7%
As of Aug 6, 2026, 4:25 AM ET
MedTech Long '25: Adv Bio Therapeutics & Regenerative Med Constituents
Arcutis Biotherapeutics, Inc.ARQT | 16.7% | 4.11% | -0.91% | 3.95% | 0.89% | -6.68% | 0.48% | 63.25% | 76.43% | $3.39B |
Halozyme Therapeutics, Inc.HALO | 16.7% | 0.43% | 2.03% | 3.48% | 1.27% | 24.21% | 20.22% | 32.64% | 34.13% | $9.91B |
InSilico Medicine Cayman TopCo3696.HK | 16.7% | -2.90% | -13.13% | 11.09% | -10.55% | 9.21% | -34.17% | 35.30% | 36.46% | $3.07B |
Orchestra BioMed Holdings, Inc.OBIO | 16.7% | -1.17% | 12.83% | 3.43% | 6.03% | 1.69% | -3.65% | 19.89% | 59.85% | $252.7M |
Vericel CorporationVCEL | 16.7% | -2.11% | 0.69% | -2.58% | -1.31% | 25.97% | 27.13% | 2.37% | 24.99% | $2.32B |
Wave Life Sciences Ltd.WVE | 16.7% | -1.17% | 2.07% | -6.17% | 7.62% | -65.12% | -57.43% | -21.66% | -30.64% | $1.17B |
| Theme return | — | -0.47% | 0.60% | -5.38% | -7.43% | -7.10% | -13.80% | 24.99% | 27.96% | — |
| Average | 16.7% | -0.47% | 0.60% | 2.20% | 0.66% | -1.79% | -7.90% | 21.97% | 33.54% | $3.35B |
| Median | 16.7% | -1.17% | 1.36% | 3.46% | 1.08% | 5.45% | -1.58% | 26.27% | 35.30% | $2.69B |
| Std Dev | 0.0% | 2.29% | 7.58% | 5.45% | 5.88% | 30.59% | 29.58% | 26.73% | 33.50% | $3.13B |
| Min | 16.7% | -2.90% | -13.13% | -6.17% | -10.55% | -65.12% | -57.43% | -21.66% | -30.64% | $252.7M |
| Max | 16.7% | 4.11% | 12.83% | 11.09% | 7.62% | 25.97% | 27.13% | 63.25% | 76.43% | $9.91B |
| % Positive Tickers | 33.33% | 66.67% | 66.67% | 66.67% | 66.67% | 50.00% | 83.33% | 83.33% |
Default: Wgt ↓ · Click headers to sort · Shift+click secondary
About this theme
MedTech Long '25: Adv Bio Therapeutics & Regenerative Med tracks 6 publicly listed stocks in this theme: 3696.HK, ARQT, HALO, OBIO, VCEL, WVE. See the constituent table for details.